Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARG.L Regulatory News (ARG)

  • There is currently no data for ARG

Rule 8.3- (Armor Group) Amend

8 Apr 2008 16:28

Citigroup Global Markets UK EqtyLtd08 April 2008 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) Amendment: this announcement replaces the announcement made on the 4th April2008 due to incorrect spelling of Company name 1. KEY INFORMATION Name of person dealing (Note 1) Citigroup Global Markets UK Equity Limited Company dealt in ArmorGroup International Plc Class of relevant security to which the Ord/Equitydealings being disclosed relate (Note 2) Date of dealing 03 April 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class ofrelevant security dealt in (Note 3) Class of relevant security: Long Short Ordinary Number (%) Number (%) (1) Relevant securities 716,061 (1.34%) (0.00%) (2) Derivatives (other than options) (0.00%) 716,061 (1.34%) (3) Options and agreements to purchase/sell (0.00%) (0.00%) Total 716,061 (1.34%) 716,061 (1.35%) (b) Interests and short positions in relevant securities of the company,other than the class dealt in (Note 3) Class of relevant security: Long Short Convertibles Number (%) Number (%) (1) Relevant securities (0.00%) (0.00%) (2) Derivatives (other than options) (0.00%) (0.00%) (3) Options and agreements to purchase/sell (0.00%) (0.00%) Total (0.00%) (0.00%) (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase Number of securities Price per unit (Note 5) 213,811 GBP 0.7636 Total: 213,811 Sale Number of securities Price per unit (Note 5) Total: (b) Derivatives transactions (other than options) Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5) e.g. CFDCFD Short 213,811 GBP 0.7636 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 7) price European etc. date paid/received per unit (Note 5) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 04 April 2008 Contact name Selina Campbell Telephone number 02890 409538 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Jun 20202:05 pmRNSSecond Price Monitoring Extn
18th Jun 20202:00 pmRNSPrice Monitoring Extension
5th Mar 202011:51 amRNSAnnual Financial Report
28th Feb 20207:00 amRNS2019 Financial Results
8th Jan 202011:05 amRNSSecond Price Monitoring Extn
8th Jan 202011:00 amRNSPrice Monitoring Extension
7th Jan 20202:05 pmRNSSecond Price Monitoring Extn
7th Jan 20202:00 pmRNSPrice Monitoring Extension
5th Nov 20192:59 pmRNSExtension of Options
1st Nov 20197:00 amRNSResult of AGM
31st Oct 20196:30 pmRNSPL001 Licence Extension
23rd Sep 20197:00 amRNS2019 Interim Financial Results
19th Sep 20197:00 amRNSNotice of Annual General Meeting
22nd Mar 20191:04 pmRNSPosting of 2018 Financial Results
18th Mar 20193:00 pmRNS2018 Financial Results
21st Feb 201910:16 amRNSCompletion of PL001 Licence Reassignment
12th Nov 20187:02 amRNSDirector/PDMR Shareholding
29th Oct 20187:00 amRNSResult of AGM
10th Oct 20182:05 pmRNSSecond Price Monitoring Extn
10th Oct 20182:00 pmRNSPrice Monitoring Extension
4th Oct 20184:40 pmRNSSecond Price Monitoring Extn
4th Oct 20184:35 pmRNSPrice Monitoring Extension
4th Oct 201810:46 amRNSPL001 Licence Reassignment
19th Sep 20187:00 amRNSNotice of AGM
21st Aug 20187:00 amRNSInterim Results
16th May 20184:40 pmRNSSecond Price Monitoring Extn
16th May 20184:35 pmRNSPrice Monitoring Extension
16th May 20182:05 pmRNSSecond Price Monitoring Extn
16th May 20182:00 pmRNSPrice Monitoring Extension
15th May 20184:40 pmRNSSecond Price Monitoring Extn
15th May 20184:35 pmRNSPrice Monitoring Extension
15th May 20189:05 amRNSSecond Price Monitoring Extn
15th May 20189:00 amRNSPrice Monitoring Extension
14th May 20184:40 pmRNSSecond Price Monitoring Extn
14th May 20184:35 pmRNSPrice Monitoring Extension
9th May 20182:05 pmRNSSecond Price Monitoring Extn
9th May 20182:00 pmRNSPrice Monitoring Extension
22nd Mar 201811:55 amRNSPosting of 2017 Financial Results
16th Mar 20187:00 amRNS2017 Financial Results
27th Oct 20177:00 amRNSResult of AGM
14th Sep 20177:00 amRNSNotice of Annual General Meeting
4th Sep 20171:18 pmRNSDirector/PDMR Shareholding
25th Aug 20174:02 pmRNS2017 Interim Financial Results
31st Mar 20171:06 pmRNSPosting of 2016 Financial Results
27th Mar 20177:00 amRNS2016 Financial Results
28th Oct 20167:00 amRNSResult of Annual General Meeting
22nd Sep 20167:00 amRNSNotice of AGM
19th Sep 20167:00 amRNS2016 Interim Financial Results
8th Aug 20162:05 pmRNSSecond Price Monitoring Extn
8th Aug 20162:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.